In this, the third interview from the 19th Annual ANZICS-CTG meeting in Noosa Heads, Australia, I'm joined by Dr Paul Young.

Paul is a prolific researcher who is well known in Australasian ICU circles.  This time, Paul and his colleagues are attempting to resolve some of the questions generated by the landmark TTM trial of therapeutic hypothermia after cardiac arrest.

The trial compared active cooling of these patients at two separate temperatures - 33 and 36 degrees celsius.  However, the question still remains as to whether cooling is necessary at all, and it may be that simply avoiding fever in these patients is sufficient.  The impact on resource consumption alone would be significant, and mandates this question be answered.